Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Motus GI to Present Pure-Vu GEN2 System at the Centers for Medicare and Medicaid Services ICD-10 Reimbursement Code Committee Meeting
Read ReleaseMotus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16
Read ReleaseMotus GI Announces U.S. Patent for the Pure-Vu® System’s Connectivity with Nearly All Commercial Colonoscopes to Provide Improved Visualization During Colonoscopy
Read ReleaseMotus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million
Read ReleaseMotus GI Announces European Clearance of Enhanced Pure-Vu® GEN2 System to Harmonize with U.S. Configuration
Read ReleaseMotus GI Expands Intellectual Property Portfolio with U.S. Patent for the Pure-Vu® System’s Universal Method to Mount on the End of Most Commercial Colonoscopes
Read ReleaseMotus GI Announces Clinical Compendium of Pure-Vu System Patient Case Studies As Reported by Several Leading U.S. Hospitals
Read Release